DE69528703T2 - VERFAHREN, REAGENZIEN UND TESTSATZ ZUR DIAGNOSE UND GEZIELTE SIEBTESTUNG FÜR p53 MÜTATIONEN - Google Patents

VERFAHREN, REAGENZIEN UND TESTSATZ ZUR DIAGNOSE UND GEZIELTE SIEBTESTUNG FÜR p53 MÜTATIONEN

Info

Publication number
DE69528703T2
DE69528703T2 DE69528703T DE69528703T DE69528703T2 DE 69528703 T2 DE69528703 T2 DE 69528703T2 DE 69528703 T DE69528703 T DE 69528703T DE 69528703 T DE69528703 T DE 69528703T DE 69528703 T2 DE69528703 T2 DE 69528703T2
Authority
DE
Germany
Prior art keywords
muttations
reagents
diagnosis
test set
screen testing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69528703T
Other languages
English (en)
Other versions
DE69528703D1 (de
Inventor
Eleftherios Diamandis
James M Dunn
John K Stevens
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Siemens Healthcare Diagnostics Inc
Original Assignee
Visible Genetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/271,946 external-priority patent/US5545527A/en
Application filed by Visible Genetics Inc filed Critical Visible Genetics Inc
Publication of DE69528703D1 publication Critical patent/DE69528703D1/de
Application granted granted Critical
Publication of DE69528703T2 publication Critical patent/DE69528703T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813Hybridisation assays
    • C12Q1/6827Hybridisation assays for detection of mutation or polymorphism
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844Nucleic acid amplification reactions
    • C12Q1/6858Allele-specific amplification
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844Nucleic acid amplification reactions
    • C12Q1/686Polymerase chain reaction [PCR]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6869Methods for sequencing
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/16Primer sets for multiplex assays
DE69528703T 1994-07-08 1995-07-07 VERFAHREN, REAGENZIEN UND TESTSATZ ZUR DIAGNOSE UND GEZIELTE SIEBTESTUNG FÜR p53 MÜTATIONEN Expired - Lifetime DE69528703T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/271,946 US5545527A (en) 1994-07-08 1994-07-08 Method for testing for mutations in DNA from a patient sample
US08/388,381 US5552283A (en) 1994-07-08 1995-02-14 Method, reagents and kit for diagnosis and targeted screening for P53 mutations
PCT/US1995/008605 WO1996001909A1 (en) 1994-07-08 1995-07-07 METHOD, REAGENTS AND KIT FOR DIAGNOSIS AND TARGETED SCREENING FOR p53 MUTATIONS

Publications (2)

Publication Number Publication Date
DE69528703D1 DE69528703D1 (de) 2002-12-05
DE69528703T2 true DE69528703T2 (de) 2003-07-17

Family

ID=26955205

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69528703T Expired - Lifetime DE69528703T2 (de) 1994-07-08 1995-07-07 VERFAHREN, REAGENZIEN UND TESTSATZ ZUR DIAGNOSE UND GEZIELTE SIEBTESTUNG FÜR p53 MÜTATIONEN

Country Status (6)

Country Link
US (1) US6071726A (de)
EP (1) EP0770145B1 (de)
AU (1) AU3094895A (de)
CA (1) CA2194697A1 (de)
DE (1) DE69528703T2 (de)
WO (1) WO1996001909A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6403303B1 (en) * 1996-05-14 2002-06-11 Visible Genetics Inc. Method and reagents for testing for mutations in the BRCA1 gene
US6013436A (en) * 1994-07-08 2000-01-11 Visible Genetics, Inc. Compositions and methods for diagnosis of mutation in the von Hippel-Lindau tumor suppressor gene
US5888736A (en) * 1995-12-22 1999-03-30 Visible Genetics, Inc. Method, compositions and kit for detection and identification of microorganisms
US5830657A (en) * 1996-05-01 1998-11-03 Visible Genetics Inc. Method for single-tube sequencing of nucleic acid polymers
US5789168A (en) * 1996-05-01 1998-08-04 Visible Genetics Inc. Method for amplification and sequencing of nucleic acid polymers
US6413718B1 (en) 1996-05-01 2002-07-02 Visible Genetics Inc. Method for sequencing of nucleic acid polymers
US6214555B1 (en) 1996-05-01 2001-04-10 Visible Genetics Inc. Method compositions and kit for detection
US6083699A (en) * 1996-05-01 2000-07-04 Visible Genetics Inc. Method for bi-directional sequencing of nucleic acid polymers
EP0914468B1 (de) * 1996-05-01 2002-08-28 Visible Genetics Inc. Verfahren zur sequenzierung von nukleinsäuren
US5830665A (en) * 1997-03-03 1998-11-03 Exact Laboratories, Inc. Contiguous genomic sequence scanning
US6333179B1 (en) 1997-06-20 2001-12-25 Affymetrix, Inc. Methods and compositions for multiplex amplification of nucleic acids
CA2302201A1 (en) * 1997-09-26 1999-04-08 Visible Genetics Inc. Method and kit for evaluation of hiv mutations
EP2365096A1 (de) * 2000-03-22 2011-09-14 Life Technologies Corporation Verfahren zur Verwendung von Halbleiternanokristallen in Nukleinsäureassays auf Kügelchenbasis
US20030049635A1 (en) * 2000-11-08 2003-03-13 City Of Hope Measurement of mutation load using the p53 gene in human cells from paraffin embedded tissues
EP2474624B1 (de) 2011-01-05 2016-08-17 Daniela Kandioler Reaktionsvorhersage bei der Krebsbehandlung (p53-adaptierte Krebstherapie)
EP2474625B1 (de) 2011-01-05 2016-11-02 Daniela Kandioler Verfahren zur Bestimmung des p53-Status in Tumoren
WO2012112245A1 (en) * 2011-02-14 2012-08-23 Beth Israel Deaconess Medical Center, Inc. Modulation of phosphatidylinositol-5-phosphate-4-kinase activity

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69032864T3 (de) * 1989-03-29 2013-01-31 The Johns Hopkins University Nachweis des Ausfalls des Wildtyps des p53-Gens
JP3179481B2 (ja) * 1990-06-27 2001-06-25 プリンストン ユニバーシティ 突然変異体p53検出用プローブ
JP3399948B2 (ja) * 1992-06-26 2003-04-28 ザ トラスティーズ オブ プリンストン ユニバーシティ P90抗体またはプローブを用いた前癌細胞または癌細胞の検出方法
US5403707A (en) * 1993-05-14 1995-04-04 Eastman Kodak Company Diagnostic compositions, elements, methods and test kits for amplification and detection of retroviral DNA using primers having matched melting temperatures
US5545527A (en) * 1994-07-08 1996-08-13 Visible Genetics Inc. Method for testing for mutations in DNA from a patient sample

Also Published As

Publication number Publication date
US6071726A (en) 2000-06-06
CA2194697A1 (en) 1996-01-25
AU3094895A (en) 1996-02-09
DE69528703D1 (de) 2002-12-05
EP0770145B1 (de) 2002-10-30
EP0770145A1 (de) 1997-05-02
WO1996001909A1 (en) 1996-01-25

Similar Documents

Publication Publication Date Title
DE69617274D1 (de) Verfahren und vorrichtung für diagnostischen dns-test
DE69528703T2 (de) VERFAHREN, REAGENZIEN UND TESTSATZ ZUR DIAGNOSE UND GEZIELTE SIEBTESTUNG FÜR p53 MÜTATIONEN
DE69839172D1 (de) Mikrobiologische Testvorrichtung und Verfahren für deren Herstellung
DE60037300D1 (de) Verfahren und Vorrichtung zur modellbasierten Diagnose
DE69829083D1 (de) Verfahren und Vorrichtung zur Diagnose elektrisch betätigter Bremsen
PL325914A1 (en) Testing apparatus, application thereof, analysing system, method of making such apparatus and method of performing tests by means of such apparatus
ATE225039T1 (de) Volumenunabhängiger diagnostischer testträger und verfahren zur bestimmung von analyten mit dessen hilfe
DE69807042D1 (de) Verfahren zum kalibrieren von sensoren in diagnostischen testverfahren
DE69932141D1 (de) Vorrichtung und Verfahren für mikrobiologische Untersuchungen
DE59802771D1 (de) Vorrichtung und verfahren zur gewinnung und erst-aufbereitung von gewebeproben für die molekulargenetische diagnostik
DE59506053D1 (de) Testset zur analyse von körperflüssigkeiten, verfahren zu seiner herstellung und analyseverfahren
DE69821865D1 (de) Ultraschall-Diagnosegerät, Verfahren zur Cursor-Darstellung, und Messgerät
DE69431746T2 (de) Verfahren und System zur Prüfung einer Anordnung und elektrische Prüfvorrichtung für eine Blitzlichteinheit
DE59911635D1 (de) System und verfahren zur diagnose von triebwerkszuständen
DE60119225D1 (de) Vorrichtung und Verfahren für Druckerdiagnose und rechnerlesbares Aufzeichungsmedium mit Druckerdiagnosefunktionsprogramm
DE69729732D1 (de) Verfahren für entwurf eines computer-gestützten automatisierten dna-diagnose tests
DE19980623T1 (de) Vorrichtung und Verfahren zur Prüfung auf Undichtigkeiten
DE69511781D1 (de) Optisches Element für photolithographie und Verfahren zur Auswertung eines optischen Elements
DE69516303D1 (de) Prüfverfahren und vorrichtung für pegelempfindliche abfragekonstruktionen
DE59409291D1 (de) Verfahren und Vorrichtung zur Massensimulation auf ortsfesten Prüfständen
DE69526347D1 (de) Mehrschichtuge testvorrichtungen und verfahren zur fructosaminbestimmung
DE69839750D1 (de) Verfahren und Vorrichtung für Diagnostik-Bilderzeugung
DE69837575D1 (de) Vorrichtung und Verfahren zur Inkubation von Teststreifen
DE69934983D1 (de) Verfahren, vorrichtung und bildgebungsmodus für tomographische bildgebung
DE68919674T2 (de) Verfahren und Gerät zur Diagnose von Netzwerken.

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: BAYER HEALTHCARE, LLC, TARRYTOWN, N.Y., US

8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: SIEMENS HEALTHCARE DIAGNOSTICS INC. (N.D.GES.D, US

8328 Change in the person/name/address of the agent

Representative=s name: MAIER, D., DIPL.-ING. UNIV., PAT.-ASS., 81739 MUEN